Teleman Dan Benjamin (CIK 2122500) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-22). Recent activity: Buy NSRX (6,550 shares), Buy NSRX (2,900 shares), Buy NSRX (15,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Nasus Pharma Ltd (NSRX) | Chief Executive Officer | Buy | 6,550 | $20,305 |
| 2026-04-22 | Nasus Pharma Ltd (NSRX) | Chief Executive Officer | Buy | 2,900 | $10,904 |
| 2026-04-01 | Nasus Pharma Ltd (NSRX) | Chief Executive Officer | Buy | 15,000 | $30,600 |
来源：SEC Form 4 申报文件 · 截至 2026-06-22